Literature DB >> 27404705

Optical coherence tomography guidance for percutaneous coronary intervention with bioresorbable scaffolds.

Gianluca Caiazzo1, Giovanni Longo2, Alessandra Giavarini2, Ismail Dogu Kilic3, Enrico Fabris4, Roberta Serdoz2, Alessio Mattesini2, Nicolas Foin5, Gioel Gabrio Secco2, Salvatore De Rosa6, Ciro Indolfi6, Carlo Di Mario7.   

Abstract

BACKGROUND: The effect of optical coherence tomography (OCT) guidance on the implantation strategy during all phases of percutaneous coronary intervention (PCI) with bioresorbable vascular scaffolds (BVSs) in a real-world scenario has been poorly investigated.
METHODS: Consecutive patients undergoing BVS implantation at our institution were included in this registry. Frequency-domain OCT pullbacks were performed at the operator's discretion during all phases of BVS implantation procedures to optimize preparation of lesions, confirm BVS size, and optimize expansion and apposition of scaffolds.
RESULTS: Between September 2012 and July 2015, 203 BVSs were implanted in 101 consecutive patients at our institution (2.01 BVSs/patient). In 66 patients, the procedure was performed under OCT guidance. In the OCT subgroup, 66 (77.6%) of the 85 treated lesions were complex (B2/C AHA/ACC type). Overall, 147 OCT pullbacks were performed and 72/147 (49.0%) pullbacks indicated the need for changing strategy. After angiography-only-guided optimisation of BVS in 27 (31.8%) lesions, an OCT examination prompted performance of a second post-expansion. This resulted in an increase in the minimal scaffold area (5.5 to 6.3mm(2), p=0.004) and a decrease in the incomplete scaffold apposition area (1.1 to 0.6mm(2), p=0.082), with no new stent fractures. When the population was divided according to the time of BVS implantation, an initial learning adaptation became evident, with the number of OCT-guided changes in strategy significantly decreasing between the initial and final time periods (p=0.017).
CONCLUSIONS: OCT guidance for BVS implantation significantly affects the procedural strategy, with favourable effects on acute results and the learning curve.
Copyright © 2016. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Bioresorbable vascular scaffold; Optical coherence tomography; Percutaneous coronary intervention

Mesh:

Year:  2016        PMID: 27404705     DOI: 10.1016/j.ijcard.2016.07.033

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  12 in total

1.  Development of a new catheter prototype for laser thrombolysis under guidance of optical coherence tomography (OCT): validation of feasibility and efficacy in a preclinical model.

Authors:  Rouven Berndt; Rene Rusch; Lars Hummitzsch; Matthias Lutz; Katharina Heß; Katharina Huenges; Bernd Panholzer; Christoph Otte; Assad Haneya; Georg Lutter; Alexander Schlaefer; Jochen Cremer; Justus Groß
Journal:  J Thromb Thrombolysis       Date:  2017-04       Impact factor: 2.300

Review 2.  Bioresorbable vascular scaffolds - basic concepts and clinical outcome.

Authors:  Ciro Indolfi; Salvatore De Rosa; Antonio Colombo
Journal:  Nat Rev Cardiol       Date:  2016-09-29       Impact factor: 32.419

3.  Climbing the hill of left main coronary artery revascularization: percutaneous coronary intervention or coronary artery bypass graft?

Authors:  Ciro Indolfi; Carmen Spaccarotella; Masakazu Yasuda; Salvatore De Rosa
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

Review 4.  BRS implantation in long lesions requiring device overlapping: myth or reality?

Authors:  Simone Biscaglia; Andrea Erriquez; Davide Bernucci; Giulia Bugani; Enrico Favaretto; Gianluca Campo
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

Review 5.  Optical coherence tomography guidance during bioresorbable vascular scaffold implantation.

Authors:  Gioel Gabrio Secco; Monica Verdoia; Gianfranco Pistis; Giuseppe De Luca; Matteo Vercellino; Andrea Audo; Rosario Parisi; Maurizio Reale; Giorgio Ballestrero; Paolo Nicola Marino; Carlo Di Mario
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

Review 6.  Long-term outcome of bioresorbable vascular scaffolds for the treatment of coronary artery disease: a meta-analysis of RCTs.

Authors:  Alberto Polimeni; Remzi Anadol; Thomas Münzel; Ciro Indolfi; Salvatore De Rosa; Tommaso Gori
Journal:  BMC Cardiovasc Disord       Date:  2017-06-07       Impact factor: 2.298

7.  Balloon postdilatation is a mandatory step in the deployment of bioresorbable vascular scaffold.

Authors:  Ahmet Karabulut
Journal:  Anatol J Cardiol       Date:  2017-01       Impact factor: 1.596

8.  Branch ostial optimization treatment and optimized provisional t-stenting with polymeric bioresorbable scaffolds: Ex-vivo morphologic and hemodynamic examination.

Authors:  Wei Cai; Lianglong Chen; Linlin Zhang; Sheng Tu; Lin Fan; Zhaoyang Chen; Yukun Luo; Xingchun Zheng
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

Review 9.  Bioresorbable Vascular Scaffolds-Dead End or Still a Rough Diamond?

Authors:  Mateusz P Jeżewski; Michał J Kubisa; Ceren Eyileten; Salvatore De Rosa; Günter Christ; Maciej Lesiak; Ciro Indolfi; Aurel Toma; Jolanta M Siller-Matula; Marek Postuła
Journal:  J Clin Med       Date:  2019-12-07       Impact factor: 4.241

10.  Optical coherence tomographic analysis of drug-eluting in-stent restenosis at different times: A STROBE compliant study.

Authors:  Chunguang Feng; Peiying Zhang; Bing Han; Xianchi Li; Yi Liu; Dongdong Niu; Yibing Shi
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.